MANZIN, ALDO
 Distribuzione geografica
Continente #
EU - Europa 132.933
NA - Nord America 10.736
AS - Asia 5.459
SA - Sud America 730
AF - Africa 258
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 150.126
Nazione #
IT - Italia 129.902
US - Stati Uniti d'America 10.591
SG - Singapore 2.099
CN - Cina 1.988
UA - Ucraina 784
BR - Brasile 554
SE - Svezia 549
VN - Vietnam 430
GB - Regno Unito 396
FI - Finlandia 340
DE - Germania 330
FR - Francia 289
HK - Hong Kong 210
IN - India 154
KR - Corea 143
NG - Nigeria 100
NL - Olanda 81
CA - Canada 75
AR - Argentina 69
BD - Bangladesh 66
MA - Marocco 51
IQ - Iraq 48
RU - Federazione Russa 47
MX - Messico 44
TR - Turchia 43
ZA - Sudafrica 38
PL - Polonia 37
JP - Giappone 34
PK - Pakistan 34
AT - Austria 26
ES - Italia 26
CO - Colombia 25
BE - Belgio 22
SA - Arabia Saudita 22
VE - Venezuela 21
EC - Ecuador 19
KE - Kenya 18
PH - Filippine 18
ID - Indonesia 17
JO - Giordania 16
TH - Thailandia 16
MY - Malesia 15
UZ - Uzbekistan 15
CZ - Repubblica Ceca 14
IE - Irlanda 14
RO - Romania 13
CL - Cile 12
IR - Iran 12
AE - Emirati Arabi Uniti 11
PY - Paraguay 11
KZ - Kazakistan 10
MU - Mauritius 10
EG - Egitto 9
TN - Tunisia 9
AL - Albania 8
IL - Israele 8
LT - Lituania 8
TW - Taiwan 8
UY - Uruguay 8
AZ - Azerbaigian 7
CH - Svizzera 7
NO - Norvegia 7
PE - Perù 7
AU - Australia 6
CR - Costa Rica 6
DZ - Algeria 6
JM - Giamaica 6
PT - Portogallo 6
BG - Bulgaria 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
LV - Lettonia 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
KW - Kuwait 3
LB - Libano 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
MD - Moldavia 2
MK - Macedonia 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
Totale 150.110
Città #
Cagliari 125.369
Uta 3.607
Singapore 1.223
Ashburn 1.034
Fairfield 984
Chandler 810
San Jose 704
Dallas 607
Woodbridge 607
Houston 597
Boardman 527
Ann Arbor 429
Wilmington 399
Jacksonville 395
Seattle 365
Cambridge 333
Beijing 316
Nyköping 313
Hefei 263
Los Angeles 251
Helsinki 204
Hong Kong 192
The Dalles 157
Nanjing 140
Santa Clara 134
Lauterbourg 132
Shanghai 128
Seoul 123
Ho Chi Minh City 116
Boston 111
Milan 102
Dearborn 99
Hanoi 94
New York 86
Buffalo 83
Council Bluffs 80
San Diego 73
Munich 68
Rome 57
Shenyang 56
São Paulo 54
Verona 49
Hangzhou 47
Jiaxing 47
Washington 45
Hebei 43
Frankfurt am Main 42
Pune 42
Chicago 40
Guangzhou 40
Nanchang 39
London 37
Changsha 34
Nuremberg 34
Tianjin 33
Casablanca 32
Warsaw 32
Orem 31
Da Nang 29
Redondo Beach 27
Tokyo 27
Amsterdam 25
Toronto 25
Zhengzhou 25
Dong Ket 24
Stockholm 24
Chennai 23
Wuhan 23
Brussels 22
Turku 22
Jinan 21
Johannesburg 21
Sassari 21
Atlanta 20
Haiphong 20
Montreal 19
Brooklyn 18
Dhaka 18
Dolianova 18
Denver 17
Manchester 17
Redwood City 17
Rio de Janeiro 16
Augusta 15
Nairobi 15
Ningbo 15
Paris 15
Vienna 15
Amman 14
Baghdad 14
Dublin 14
Phoenix 14
Poplar 14
Port Harcourt 14
Biên Hòa 13
Mexico City 13
Norwalk 13
Porto Alegre 13
Saint Petersburg 13
Tashkent 13
Totale 142.865
Nome #
null 4.609
GUT MICROBIAL PROFILE IN WEIGHT CYCLING PATIENTS WITH OBESITY 4.542
Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients 3.943
H-1 NMR spectroscopy-based metabolomics analysis for the diagnosis of symptomatic E. coli-associated urinary tract infection (UTI) 3.837
Caratterizzazione di un ceppo di Listeria monocytogenes isolato da emocoltura 3.290
Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin 3.019
Usefulness of capillary electrophoresis-based multiplex PCR assay for species-specific identification of Candida spp. 2.655
RT-QuIC assay for the detection of PrPsCJD spiked into human urine 2.596
CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients 2.576
Role of PCR in Helicobacter pylori diagnostics and research - new approaches for study of coccoid and spiral forms of the bacteria 2.469
null 2.467
Streptococcus suis meningitis without history of animal contact, Italy 2.415
Genetic variants of TAS2R38 bitter taste receptor associate with distinct gut microbiota traits in Parkinson's disease: A pilot study 2.374
Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman 2.342
Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease 2.334
Global impact of Torque teno virus infection in wild and domesticated animals 2.297
Distinct signatures of the gut microbiome in an Italian cohort of patients with Parkinson’s Disease 2.175
High prevalence of co-infection with multiple torque teno sus virus species in Italian pig herds 2.166
Dynamics of TT virus infection in a cohort of HCV-infected patients achieving sustained virologic responce after treatment with direct-acting antivirals 2.166
Gut microbiome signatures, clinical phenotypes and drugs in Parkinson’s disease 2.088
Impact of a Moderately Hypocaloric Mediterranean Diet on the Gut Microbiota Composition of Italian Obese Patients 2.051
Lack of KIs virus DNA in plasma and cerebrospinal fluid in Italy 1.954
Cyclovirus Vietnam DNA in immunodeficient patients 1.929
RT-QuIC assay for the in vivo detection of PrPsCJD from the cerebrospinal fluid of CJD-suspected cases at early clinical stage of disease 1.929
Lack of usutu virus RNA in cerebrospinal fluid of patients with encephalitis of unknown etiology, Tuscany, Italy 1.840
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.685
Bovine viral diarrhea virus (BVDV): A preliminary study on antiviral properties of some aromatic and medicinal plants 1.584
Epitope mapping of human antibody response against HCV/E2 glycoproteinby generation of monoclonal recombinant fabs 1.441
Human Arthropod-Borne Viral Infections 1.428
Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I) 1.413
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.314
Composite structure of Streptococcus pneumoniae containing the erythromycin efflux resistance gene mefI and the chloramphenicol resistance gene catQ 1.287
Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy 1.236
Viroidi, Virus dell'epatite E e Poxviridae 1.222
New Tn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci 1.215
High incidence of EBV-reactivation and PTLD in adults receiving a cord blood transplant with reduced-intensity conditioning regimen 1.191
Human Arthropod-Borne Viral Infections 1.159
Genetic diversity of Streptococcus suis clinical isolates from pigs and humans in Italy (2003-2007) 1.107
Determinazione quantitativa di HCV-RNA: valutazione comparativa dei saggi Abbott Real-Time e Versant bDNA v.3 1.075
Metabolic Alteration in Plasma and Biopsies From Patients With IBD 1.071
Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy 1.055
Gut microbiota markers associated with obesity and overweight in Italian adults 1.001
Prophage association of mef(A) elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes 994
Diet-Derived Antioxidants and Their Role in Inflammation, Obesity and Gut Microbiota Modulation 978
Acute myocarditis associated with adenoviral infection in a patient with scleroderma 944
Clinical phenotypes of Parkinson’s disease associate with distinct gut microbiota and metabolome enterotypes 941
Uncomplicated UTIs and old antimicrobials: a retrospective study on southern Sardinian population 921
Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa-carbidopa intrajejunal gel 890
Bichromonol, a dimeric coumarin with anti-HIV activity from the stem bark of Hypericum roeperianum 885
Molecular study and epitope mapping of the human antibody response against HCV/E2 glycoprotein by generation of monoclonal recombinant Fabs 876
Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 836
Gut Microbiota Markers and Dietary Habits Associated with Extreme Longevity in Healthy Sardinian Centenarians 834
Metabolomic profile of systemic sclerosis patients 828
LONG-TERM BENEFICIAL EFFECTS IN SUSTAINED RESPONDERS TO INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS C 811
SARS-CoV-2 and Its Variants: The Pandemic of Unvaccinated 810
Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose 754
More evidence on safety of intramascular immune serum globulin produced from plasma unscreened for anti-hepatitis C virus antibodies 750
null 728
Non-neutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs 723
Anthraquinone Rhein Exhibits Antibacterial Activity against Staphylococcus aureus 694
Parkinson’s disease: A prionopathy? 690
Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients 664
Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets 663
QUANTITATIVE LIVER PARAMETERS OF HCV INFECTION: RELATION TO HCV GENOTYPES, VIREMIA AND RESPONSE TO INTERFERON TREATMENT 653
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients 651
Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C 648
Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro 624
Dynamics of hepatitis C viremia after plasma exchange 612
Nasopharyngeal virome analysis of COVID-19 patients during three different waves in Campania Region of Italy 612
TOFE HUMAN-B-CELL-LINE-BASED ADSORPTION-INHIBITION ASSAY TO DETECT HCV NEUTRALIZING ANTIBODIES 610
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson's disease 608
Hepatitis C virus infection after orthotopic liver transplantation | [L'INFEZIONE DA VIRUS DELL'EPATITE C DOPO TRAPIANTO ORTOTOPICO DI FEGATO] 602
Dissection of human humoral immuneresponse against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments 595
Antimicrobial effectiveness of ozonated olive and sunflower seeds oils 589
Long-term lymphoblastoid interferon-α therapy for non-cirrhotic chronic hepatitis C: An Italian multicentre study on dose and duration of IFNα treatment 583
Exacerbation of chronic hepatitis D during interferon alpha administration 575
Spike-mediated viral membrane fusion is inhibited by a specific anti-IFITM2 monoclonal antibody 567
SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection 567
null 552
PROPHYLAXIS OF HEPATITIS C WITH INTRAMUSCULAR IMMUNOGLOBULIN: CLINICAL AND ECONOMIC APPRAISAL 551
null 547
Dynamics of Gut Microbiota and Clinical Variables after Ketogenic and Mediterranean Diets in Drug-Naïve Patients with Type 2 Diabetes Mellitus and Obesity 542
Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic 531
Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange 529
null 526
Evolution of hypervariable region 1 of hepatitis C virus in primary infection 523
SEXUAL TRANSMISSION OF HEPATITIS C VIRUS AND PREVENTION WITH INTRAMUSCULAR IMMUNOGLOBULIN 516
null 512
null 504
Hylin-a1: A Pan-Inhibitor against Emerging and Re-Emerging Respiratory Viruses 497
Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact 493
RiV4PoC: A high effective microbicidal coating for high-touch surfaces 485
Physico-Chemical Investigation and Antimicrobial Efficacy of Ozonated Oils: The Case Study of Commercial Ozonated Olive and Sunflower Seed Refined Oils 483
Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy 472
null 470
QUANTITATIVE ANALYSIS OF HEPATITIS C VIRUS ACTIVITY IN VIVO IN DIFFERENT GROUPS OF UNTREATED PATIENTS 467
PCR ANALYSIS OF HBV INFECTED SERA: RELATIONSHIP BETWEEN EXPRESSION OF PRE-S ANTIGENS AND VIRAL REPLICATION 463
A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction 461
Design of Three Residues Peptides against SARS-CoV-2 Infection 460
CHARACTERIZATION OF HEPATITIS C VIRUS GENOTYPES IN AN HEMODIALYSIS UNIT IN PAYSANDú, URUGUAY 459
Totale 124.900
Categoria #
all - tutte 210.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.228 0 0 0 0 0 0 0 0 0 2.010 1.958 1.260
2021/20229.724 970 627 550 722 993 618 406 554 875 1.074 1.183 1.152
2022/202314.215 935 1.613 1.765 1.074 1.087 1.432 751 1.394 1.162 995 1.359 648
2023/202415.598 833 571 645 1.072 1.541 3.022 1.691 1.412 735 1.264 1.436 1.376
2024/202529.609 6.014 9.199 3.827 3.489 1.568 1.757 1.765 275 330 338 367 680
2025/202611.220 744 718 1.225 951 896 917 2.973 691 957 1.148 0 0
Totale 150.563